Cargando…
Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
The prevalence of SARS-CoV-2 variants of concern (VOCs) is still escalating throughout the world. However, the level of neutralization of the inactivated viral vaccine recipients’ sera and convalescent sera against all VOCs, including B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), B.1.617.2 (Delta),...
Autores principales: | Zhu, Yuqi, Yang, Xinyi, Xun, Jingna, Liu, Jun, Wen, Qing, Lin, Yixiao, Shen, Xiaoting, Chen, Jun, Yuan, Songhua, Zhao, Xiaying, Wang, Jing, Pan, Hanyu, Yang, Jinlong, Liang, Zhiming, Liang, Yue, Lin, Qinru, Liang, Huitong, Li, Min, Liu, Jianping, Shen, Yinzhong, Zhang, Xiaoyan, Wang, Pengfei, Lu, Daru, Yin, Chunhua, Xu, Jianqing, Jiang, Shibo, Lu, Hongzhou, Zhu, Huanzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wuhan Institute of Virology, Chinese Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605785/ https://www.ncbi.nlm.nih.gov/pubmed/36309305 http://dx.doi.org/10.1016/j.virs.2022.10.006 |
Ejemplares similares
-
The neutralization of B.1.617.1 and B.1.1.529 sera from convalescent patients and BBIBP-CorV vaccines
por: Yang, Xinyi, et al.
Publicado: (2022) -
BBIBP-CorV: Hepatitis: case report
Publicado: (2022) -
BBIBP-CorV: Anterior uveitis: case report
Publicado: (2022) -
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
por: Jeewandara, Chandima, et al.
Publicado: (2022) -
BBIBP-CorV: Steven-Johnson syndrome : case report
Publicado: (2022)